Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.32 |
| ▸ | CES1 | P23141 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
| ▸ | PLA2G4C | Q9UP65 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17830590 | 0.95 | FAAH (0.31) | FAAHCES1 | |
| SCHEMBL17830575 | 0.95 | ACLY (0.34) | FAAHCES1 | |
| SCHEMBL17830621 | 0.95 | FAAH (0.31) | FAAHCES1 | |
| SCHEMBL17830573 | 0.93 | FAAH (0.32) | FAAHCES1ALDH1A1PLA2G4BMAPT | |
| SCHEMBL17830496 | 0.91 | ACLY (0.34) | FAAHCES1 | |
| SCHEMBL17830511 | 0.89 | — | — | |
| SCHEMBL17830556 | 0.85 | — | — | |
| SCHEMBL17830672 | 0.84 | FAAH (0.31) | FAAHCES1 | |
| SCHEMBL17830646 | 0.83 | — | — | |
| SCHEMBL17830675 | 0.82 | FAAH (0.33) | FAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9850428-B2 | Compound having poly (difluoromethylene) chain, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-9850428-B2 | Compound having poly (difluoromethylene) chain, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-20160168466-A1 | COMPOUND HAVING POLY (DIFLUOROMETHYLENE) CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160168466-A1 | COMPOUND HAVING POLY (DIFLUOROMETHYLENE) CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168466-A1 | COMPOUND HAVING POLY (DIFLUOROMETHYLENE) CHAIN, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, F12, C1S | FAAH 415/4885CES1 1055/4885ALDH1A1 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.